AnalystsGraig Suvannavejh
Graig Suvannavejh's Stock Forecasts

Analyst Ranking
Bottom 14%
#4254 out of 4904 analysts
Average Return
-0.52%
Win Rate
48%59 out of 123
Risk vs Reward
Poor
Good

Graig Suvannavejh's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Insmed IncINSM
+266.11%$20.36$74.54
2023-07-26 -
2024-07-26
Strong Buy
Insmed IncINSM
+197.15%$23.88$70.96
2023-10-27 -
2024-10-25
Strong Buy
Insmed IncINSM
+168.79%$26.43$71.04
2023-09-06 -
2024-09-06
Strong Buy
Insmed IncINSM
+162.29%$25.83$67.75
2024-05-13 -
2025-05-12
Strong Buy
Halozyme Therapeutics IncHALO
+136.15%$18.45$43.57
2020-01-08 -
2021-01-08
Strong Buy

Graig Suvannavejh Analyst Color

Get additional color on Graig Suvannavejh's coverage of popular stocks

Graig Suvannavejh's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Insmed IncINSM
7Buy$110.00+13.54%Maintains
2 days ago
Corvus Pharmaceuticals IncCRVS
2Buy$11.00+159.43%Maintains
25 days ago
Eyepoint Pharmaceuticals IncEYPT
5Buy$26.00+193.45%Maintains
a month ago
Harmony Biosciences Holdings IncHRMY
18Buy$48.00+44.01%Maintains
a month ago
Apellis Pharmaceuticals IncAPLS
7Hold$20.00+3.84%Maintains
a month ago
Amylyx Pharmaceuticals IncAMLX
7Buy$8.00+44.93%Maintains
a month ago
Immunocore Holdings PLCIMCR
8Hold$33.00-7.38%Maintains
2 months ago
Axsome Therapeutics IncAXSM
21Buy$216.00+103.29%Maintains
3 months ago
Intra Cellular Therapies IncITCI
11Hold$132.00+0.10%Downgrades
4 months ago
Adaptimmune Therapeutics PLCADAP
2Buy$1.50+509.76%Maintains
7 months ago
Autolus Therapeutics PLCAUTL
1Strong Buy$7.60+253.49%Upgrades
7 months ago
Corbus Pharmaceuticals Holdings IncCRBP
1Buy$74.00+706.98%Reiterates
9 months ago
Athira Pharma IncATHA
3Hold$0.50+61.81%Downgrades
9 months ago
Halozyme Therapeutics IncHALO
4Hold$49.00-10.16%Maintains
a year ago
Ideaya Biosciences IncIDYA
1Buy$50.00+124.42%Initiates Coverage On
a year ago
Neumora Therapeutics IncNMRA
1Buy$20.00+2,127.17%Initiates Coverage On
a year ago
Immatics NvIMTX
3Strong Buy$16.00N/AMaintains
a year ago
Adverum Biotechnologies IncADVM
4Strong Buy$22.00N/AMaintains
a year ago
Immuneering CorpIMRX
1Strong Buy$8.00N/AMaintains
a year ago
Cerevel Therapeutics Holdings IncCERE
9Hold$45.00N/AMaintains
a year ago
Terns Pharmaceuticals IncTERN
5Strong Buy$10.00N/AMaintains
2 years ago
Alector IncALEC
4Strong Buy$9.00N/AMaintains
2 years ago
Bioxcel Therapeutics IncBTAI
8Hold$64.00N/AReiterates
2 years ago
Karuna Therapeutics IncKRTX
3Strong Buy$258.00N/AMaintains
2 years ago
Rain Oncology IncRAIN2
5Hold$1.00N/ADowngrades
2 years ago
Vigil Neuroscience IncVIGL
1Strong Buy$15.00N/AInitiates Coverage On
2 years ago
Rhythm Pharmaceuticals IncRYTM
3Strong Buy$35.00N/AMaintains
3 years ago
Kodiak Sciences IncKOD
4Hold$8.00N/AMaintains
3 years ago
Tg Therapeutics IncTGTX
2Strong Sell$26.00N/ADowngrades
4 years ago
Disc Medicine IncIRON
2Strong Buy$18.00N/AMaintains
4 years ago
Valneva SeVALN
1Strong Buy$34.00N/AInitiates Coverage On
4 years ago
Design Therapeutics IncDSGN
1Hold$28.00N/AInitiates Coverage On
4 years ago
Edgewise Therapeutics IncEWTX
1Hold$31.00N/AInitiates Coverage On
4 years ago
Vor Biopharma IncVOR
1Strong Sell$19.00N/AInitiates Coverage On
4 years ago
Innate Pharma SaIPHA
1Hold$4.75N/AInitiates Coverage On
5 years ago
Arcutis Biotherapeutics IncARQT
2Strong Buy$36.00N/AUpgrades
5 years ago
Cytokinetics IncCYTK
1Hold$16.00N/AInitiates Coverage On
5 years ago
Galapagos NvGLPG
1Strong SellN/AN/ADowngrades
5 years ago
Prelude Therapeutics IncPRLD
1Hold$37.00N/AInitiates Coverage On
5 years ago
Jazz Pharmaceuticals PLCJAZZ
1Strong Sell$128.00N/ADowngrades
5 years ago
Tricida IncTCDAQ
1Hold$10.00N/ADowngrades
5 years ago
Flexion Therapeutics IncFLXN
1Hold$15.00N/AInitiates Coverage On
5 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$29.00N/AInitiates Coverage On
5 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$35.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.